Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses(417 views) Soricelli A, Postiglione A, GrivetFojaja M, Mainenti PP, Discepolo A, Varrone A, Salvatore M, Lassen N
Affiliations: Department of Diagnostic Imaging, University of Naples Federico II, Nucl. Med. Ctr. Natl. Res. Cncl., Naples, Italy
Dept. of Clin. and Exp. Medicine, University of Naples Federico II, Naples, Italy
Dept. of Nucl. Med./Clin. Physiology, Bispebjerg Hospital, Copenhagen, Denmark
Univ. Studi di Napoli Federico II, Facolta' di Medicina e Chirurgia, Dept. of Clin. and Exp. Medicine, Via S. Pansini 5, I-80131 Napoli, Italy
References: Nordberg, A., Neuroreceptor changes in Alzheimer disease (1992) Cerebrovasc Brain Metab Rev, 4, pp. 303-32
Greenamyre, J.T., Maragos, F., Neurotransmitter receptors in Alzheimer disease (1993) Cerebrovasc Brain Metab Rev, 5, pp. 61-94
Oslen, R.W., The GABA postsynaptic membrane receptor ionophore complex (1981) Mol Cell Biochem, 39, pp. 261-279
Hunkeler, W., Möhler, H., Pieri, L., Selective antagonist of benzodiazepines (1981) Nature, 290, pp. 514-516
Shinotoh, H., Yamasaki, T., Inoue, O., Itoh, T., Suzuki, K., Hashimoto, K., Tateno, Y., Ikeria, H., Visualization of specific binding sites of benzodiazepine in human brain (1986) J Nucl Med, 27, pp. 1593-1599
Beer, H.F., Blauentein, P.A., Hasler, P.H., Delaloye, B., Riccabona, G., Bangerl, I., Hunkeler, W., Schubiger, P.A., In vivo and in vitro evaluation of iodine 123-RO16-0154: A new imaging agent for SPECT investigations of benzodiazepine receptors (1990) J Nucl Med, 31, pp. 1007-1014
Videboek, C., Friberg, L., Holm, S., Wammen, S., Foged, C., Andersen, J.V., Dalgaard, L., Lassen, N.A., Benzodiazepine receptor equilibrium constants for flumazenil and medazolam determined in humans with the single photon emission computer tomography trace (123-I)iomazenil (1993) Eur J Pharmacol, 249, pp. 43-51
Abi-Dargham, A., Laruelle, M., Seibyl, J., Rattner, Z., Baldwin, R.M., Zoghbi, S.S., Zea-Ponce, Y., Innis, R.B., SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: Kinetic and equilibrium paradigms (1994) J Nucl Med, 35, pp. 228-238
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E.M., Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA work group (1984) Neurology, 34, pp. 939-944
Laurell, M., Van Dyck, C., Abi-Dargham, A., Zea-Ponche, Y., Zoghbai, S., Charney, D., Baldwin, R., Innies, R., Compartmental modeling of iodine-123 iodo-benzofuran binding to dopamine D2 receptors in healthy subjects (1994) J Nucl Med, 35, pp. 743-754
Onishi, Y., Yonekura, Y., Mukai, T., Nishizawa, S., Tanaka, F., Okazawa, H., Ishizu, K., Konishi, J., Simple quantification of benzodiazepine receptor binding and ligand transport using iodine-123-iomazenil and two SPECT scans (1995) J Nucl Med, 36, pp. 1201-1210
Iida, H., Itoh, H., Bloomfield, P., Masahiro, M., Shuichi, H., Matsutaro, M., Atsushi, I., Kazuo, U., A method to quantitate cerebral blood flow using a rotating gamma camera and iodine-123 iodamphetamine with one blood sample (1994) Eur J Nucl Med, 21, pp. 1072-1084
Odano, I., Takahashi, N., Ohkubo, M., Yonekura, Y., SPECT measurement of benzodiazepine receptors in patients with Parkinson's disease with iodine-123 labeled iomazenil (1995) J Nucl Med, 36, pp. 241P
De Kosky, S.T., Bass, N.H., Biochemistry of senile dementia (1985) Handbook of Neurochemistry, pp. 617-649. , Lajtha A, ed. New York: Plenum Press
Davies, C.A., Mann, D.M., Sumpter, P.Q., Yates, P.O., A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease (1987) J Neurol Sci, 78, pp. 151-164
Schell, S.W., De Kosky, S.T., Price, D.A., Quantitative assessment of cortical synaptic density in Alzheimer's disease (1990) Neurobiol Aging, 11, pp. 29-37
Masliah, E., Terry, R.D., De Teresa, R.M., Hansen, L.A., Immunohistochemical quantification of the synapse related protein synaptophysin in Alzheimer's disease (1989) Neurosci Lett, 103, pp. 234-239
Hamos, J.E., De Gennaro, L.J., Drachman, D.A., Synaptic loss in Alzheimer's disease and other dementias (1989) Neurology, 39, pp. 355-361
Terry, R.D., Masliah, E., Salmon, D.P., Butters, N., De Teresa, R., Hill, R., Hansen, L.A., Katzman, R., Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment (1991) Ann Neurol, 30, pp. 572-580
Kanno, I., Lassen, N.A., Two methods for calculation of regional cerebral blood flow from emission computed tomography of inert gas concentrations (1979) J Comput Assist Tomogr, 3, pp. 71-76
Rapoport, S.I., Positron emission tomography in Alzheimer's disease in relation to pathogenesis: A critical review (1991) Cerebrovasc Brain Metab Rev, 3, pp. 297-335
Waldemar, G., Functional brain imaging with SPECT in normal aging and dementia (1995) Cerebrovasc Brain Metab Rev, 7, pp. 89-130
Weinberger, D.R., Jones, D., Reba, R.C., Mann, U., Coppola, R., Gibson, R., Gorey, J., Chase, T.N., A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia (1992) J Neuropyschiatry Clin Neurosci, 4, pp. 239-248
Wyper, D.J., Brown, D., Patterson, J., Owens, J., Hunter, R., Teasdale, E., McCulloch, J., Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease (1993) Eur J Nucl Med, 20, pp. 379-386
Greenamyre, J. T., Maragos, F., Neurotransmitter receptors in Alzheimer disease (1993) Cerebrovasc Brain Metab Rev, 5, pp. 61-94
Oslen, R. W., The GABA postsynaptic membrane receptor ionophore complex (1981) Mol Cell Biochem, 39, pp. 261-279
Hunkeler, W., M hler, H., Pieri, L., Selective antagonist of benzodiazepines (1981) Nature, 290, pp. 514-516
Beer, H. F., Blauentein, P. A., Hasler, P. H., Delaloye, B., Riccabona, G., Bangerl, I., Hunkeler, W., Schubiger, P. A., In vivo and in vitro evaluation of iodine 123-RO16-0154: A new imaging agent for SPECT investigations of benzodiazepine receptors (1990) J Nucl Med, 31, pp. 1007-1014
De Kosky, S. T., Bass, N. H., Biochemistry of senile dementia (1985) Handbook of Neurochemistry, pp. 617-649. , Lajtha A, ed. New York: Plenum Press
Davies, C. A., Mann, D. M., Sumpter, P. Q., Yates, P. O., A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease (1987) J Neurol Sci, 78, pp. 151-164
Schell, S. W., De Kosky, S. T., Price, D. A., Quantitative assessment of cortical synaptic density in Alzheimer's disease (1990) Neurobiol Aging, 11, pp. 29-37
Hamos, J. E., De Gennaro, L. J., Drachman, D. A., Synaptic loss in Alzheimer's disease and other dementias (1989) Neurology, 39, pp. 355-361
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., De Teresa, R., Hill, R., Hansen, L. A., Katzman, R., Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment (1991) Ann Neurol, 30, pp. 572-580
Rapoport, S. I., Positron emission tomography in Alzheimer's disease in relation to pathogenesis: A critical review (1991) Cerebrovasc Brain Metab Rev, 3, pp. 297-335
Weinberger, D. R., Jones, D., Reba, R. C., Mann, U., Coppola, R., Gibson, R., Gorey, J., Chase, T. N., A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia (1992) J Neuropyschiatry Clin Neurosci, 4, pp. 239-248
Wyper, D. J., Brown, D., Patterson, J., Owens, J., Hunter, R., Teasdale, E., McCulloch, J., Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease (1993) Eur J Nucl Med, 20, pp. 379-386
Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses
Iodine-123 labelled iomazenil (IMZ) is a specific tracer for the GABA(A) receptor, the dominant inhibitory synapse of the brain. The cerebral distribution volume (V(d)) of IMZ may be taken as a quantitative measure of these synapses in Alzheimer's disease (AD), where synaptic loss tends indiscriminately to affect all cortical neurons, albeit more so in some areas than in others. In this pilot study we measured V(d) in six patients with probable AD and in five age-matched controls using a brain-dedicated single-photon emission tomography scanner allowing all cortical levels to be sampled simultaneously. Reduced values were found in all regions except in the occipital (visual) cortex. In particular, temporal and parietal cortex V(d) was significantly (P < 0.02) reduced: temporal V(d) averaged 69 ml/ml in normals and 51 ml/ml in AD, and parietal V(d) averaged 71 ml/ml in normals and 48 ml/ml in AD, These results accord well with emission tomographic studies of blood flow or labelled glucose. This supports the idea that while only measuring a subpopulation of synapses, the IMZ method reflects synaptic loss and hence functional loss in AD. The method constitutes an in vivo version of synaptic quantitation that in histopathological studies has been shown to correlate closely with the mental deterioration in AD.
Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G * Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation(1002 views) Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806. Impact Factor:8.017 ViewExport to BibTeXExport to EndNote